Cargando…
Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report
BACKGROUND: Current evidence linking the development of Parkinson’s disease after the use of 3,4-methylenedioxymethamphetamine is mixed and limited, with only a few positive case reports demonstrating this. CASE PRESENTATION: We examine this interesting case of a 49-year-old Chinese gentleman who us...
Autores principales: | Hui, Tianyi, Guo, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517548/ https://www.ncbi.nlm.nih.gov/pubmed/37740189 http://dx.doi.org/10.1186/s13256-023-04147-x |
Ejemplares similares
-
Substance-induced anxiety disorder after one dose of 3,4-methylenedioxymethamphetamine: a case report
por: Kaplan, Kaeley, et al.
Publicado: (2018) -
3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013) -
3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015) -
Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011) -
Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)